Preclinical and Clinical Pharmacology of Vinca Alkaloids (Q35168007)

6 August 2017

1 reference

title

Preclinical and clinical pharmacology of vinca alkaloids (English)

1 reference

6 August 2017

Preclinical and Clinical Pharmacology of Vinca Alkaloids (English)

1 reference

10.2165/00003495-199200444-00002

Crossref

DOI

https://api.crossref.org/works/10.2165/00003495-199200444-00002

23 November 2023

1 reference

X. J. Zhou

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1283846

9 September 2022

R. Rahmani

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1283846

9 September 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1283846

9 September 2022

publication date

1 January 1992

1 reference

6 August 2017

1 reference

6 August 2017

volume

44 Suppl 4

1 reference

6 August 2017

page(s)

1-16; discussion 66-9

1 reference

The pharmacokinetics of vincristine in man: reduced drug clearance associated with raised serum alkaline phosphatase and dose-limited elimination

6 August 2017

cites work

1 reference

https://pubmed.ncbi.nlm.nih.gov/1283846

12 December 2020

Pharmacokinetics of vincristine infusion

1 reference

https://pubmed.ncbi.nlm.nih.gov/1283846

12 December 2020

Uptake and binding of vincristine by murine leukemia cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/1283846

12 December 2020

Adriamycin accumulation and metabolism in adriamycin-sensitive and -resistant human ovarian cancer cell lines

1 reference

https://pubmed.ncbi.nlm.nih.gov/1283846

12 December 2020

ATP-binding site of adenylate kinase: mechanistic implications of its homology with ras-encoded p21, F1-ATPase, and other nucleotide-binding proteins

1 reference

https://pubmed.ncbi.nlm.nih.gov/1283846

12 December 2020

Solid-phase extraction of vinblastine and vincristine from plasma and urine: variable drug recoveries due to non-reproducible column packings

1 reference

https://pubmed.ncbi.nlm.nih.gov/1283846

12 December 2020

Interpatient and intrapatient variability in vinblastine pharmacokinetics

1 reference

https://pubmed.ncbi.nlm.nih.gov/1283846

12 December 2020

Vinblastine pharmacokinetics measured by a sensitive enzyme-linked immunosorbent assay

1 reference

https://pubmed.ncbi.nlm.nih.gov/1283846

12 December 2020

Phase I trial of vinzolidine

1 reference

https://pubmed.ncbi.nlm.nih.gov/1283846

12 December 2020

A 125I-radiolabelled probe for vinblastine and vindesine radioimmunoassays: applications to measurements of vindesine plasma levels in man after intravenous injections and long-term infusions

1 reference

https://pubmed.ncbi.nlm.nih.gov/1283846

12 December 2020

Multidrug-resistance phenotype in Chinese hamster ovary cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/1283846

12 December 2020

Radioimmunoassay and preliminary pharmacokinetic studies in rats of 5'-noranhydrovinblastine (navelbine)

1 reference

https://pubmed.ncbi.nlm.nih.gov/1283846

12 December 2020

Pharmacokinetics of navelbine after oral administration in cancer patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/1283846

12 December 2020

Amplification of P-glycoprotein genes in multidrug-resistant mammalian cell lines

1 reference

https://pubmed.ncbi.nlm.nih.gov/1283846

12 December 2020

Cross-resistance patterns and antigen expression in Vinca alkaloid- and other multiple drug-resistant human leukemic cell lines

1 reference

https://pubmed.ncbi.nlm.nih.gov/1283846

12 December 2020

Cell Surface P-Glycoprotein Associated with Multidrug Resistance in Mammalian Cell Lines

1 reference

https://pubmed.ncbi.nlm.nih.gov/1283846

12 December 2020

Experimental antitumor activity of 5'-nor-anhydrovinblastine navelbine

1 reference

https://pubmed.ncbi.nlm.nih.gov/1283846

12 December 2020

An enzyme-linked immunosorbent assay for the antineoplastic agent vincristine

1 reference

https://pubmed.ncbi.nlm.nih.gov/1283846

12 December 2020

Determination of vinca alkaloids in plasma and urine using ion-exchange chromatography on silica gel and fluorescence detection

1 reference

https://pubmed.ncbi.nlm.nih.gov/1283846

12 December 2020

Determination of navelbine and desacetylnavelbine in biological fluids by high-performance liquid chromatography

1 reference

https://pubmed.ncbi.nlm.nih.gov/1283846

12 December 2020

In vivo and in vitro pharmacokinetics and metabolism of vincaalkaloids in rat. II. Vinblastine and vincristine

1 reference

https://pubmed.ncbi.nlm.nih.gov/1283846

12 December 2020

Specific radioimmunoassay for vincristine

1 reference

https://pubmed.ncbi.nlm.nih.gov/1283846

12 December 2020

1 reference

https://pubmed.ncbi.nlm.nih.gov/1283846

12 December 2020

Active outward transport of daunomycin in resistant Ehrlich ascites tumor cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/1283846

12 December 2020

A sensitive radioimmunoassay for vincristine and vinblastine

1 reference

https://pubmed.ncbi.nlm.nih.gov/1283846

12 December 2020

Decreased retention of actinomycin D as the basis for cross-resistance in anthracycline-resistant sublines of P388 leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/1283846

12 December 2020

Clinical pharmacokinetics of the antitumor drug navelbine (5'-noranhydrovinblastine)

1 reference

https://pubmed.ncbi.nlm.nih.gov/1283846

12 December 2020

Potentiation of vincristine and Adriamycin effects in human hemopoietic tumor cell lines by calcium antagonists and calmodulin inhibitors.

1 reference

https://pubmed.ncbi.nlm.nih.gov/1283846

12 December 2020

Tubulin and calmodulin. Effects of microtubule and microfilament inhibitors on localization in the mitotic apparatus

1 reference

https://pubmed.ncbi.nlm.nih.gov/1283846

12 December 2020

Experimental in vivo cross-resistance of vinca alkaloid drugs

1 reference

https://pubmed.ncbi.nlm.nih.gov/1283846

12 December 2020

Sensitive method for the determination of vincristine in human serum by high-performance liquid chromatography after on-line column-extraction

1 reference

https://pubmed.ncbi.nlm.nih.gov/1283846

12 December 2020

Altered surface membrane glycoproteins in Vinca alkaloid-resistant human leukemic lymphoblasts

1 reference

https://pubmed.ncbi.nlm.nih.gov/1283846

12 December 2020

Vinca alkaloid-resistant phenotype in cultured human leukemic lymphoblasts

1 reference

https://pubmed.ncbi.nlm.nih.gov/1283846

12 December 2020

Therapeutic selectivity of vinca alkaloids: a role for guanosine 5'-triphosphate?

1 reference

https://pubmed.ncbi.nlm.nih.gov/1283846

12 December 2020

Vinca-23-oyl amino acid derivatives: as new anticancer agents (review).

1 reference

https://pubmed.ncbi.nlm.nih.gov/1283846

12 December 2020

Disposition of the monoclonal antibody-vinca alkaloid conjugate, KS1/4-DAVLB (LY256787), in Fischer 344 rats and rhesus monkeys

1 reference

https://pubmed.ncbi.nlm.nih.gov/1283846

12 December 2020

The comparative clinical pharmacology and pharmacokinetics of vindesine, vincristine, and vinblastine in human patients with cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/1283846

12 December 2020

Disposition of the monoclonal antibody-vinca alkaloid conjugate KS1/4-DAVLB (LY256787) and free 4-desacetylvinblastine in tumor-bearing nude mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/1283846

12 December 2020

Extrapolation of preclinical pharmacokinetic data to therapeutic drug use.

1 reference

https://pubmed.ncbi.nlm.nih.gov/1283846

12 December 2020

A new class of antitumor compounds: 5'-nor and 5',6'-seco derivatives of vinblastine-type alkaloids

1 reference

https://pubmed.ncbi.nlm.nih.gov/1283846

12 December 2020

Clinical pharmacokinetics of vindesine: repeated treatments by intravenous bolus injections

1 reference

https://pubmed.ncbi.nlm.nih.gov/1283846

12 December 2020

Clinical pharmacokinetics of vinblastine by continuous intravenous infusion

1 reference

https://pubmed.ncbi.nlm.nih.gov/1283846

12 December 2020

The multidrug resistant phenotype in clinical practice; evaluation of cross resistance to ifosfamide and mesna after VP16-213, doxorubicin and vincristine (VPAV) for small cell lung cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/1283846

12 December 2020

Phase I and pharmacological study of vinblastine by prolonged continuous infusion

1 reference

https://pubmed.ncbi.nlm.nih.gov/1283846

12 December 2020

Cellular uptake and tubulin binding properties of four Vinca alkaloids

1 reference

https://pubmed.ncbi.nlm.nih.gov/1283846

12 December 2020

Pharmacology, Clinical Efficacy and Adverse Effects of Vindesine Sulfate, A New Vinca Alkaloid

1 reference

https://pubmed.ncbi.nlm.nih.gov/1283846

12 December 2020

Analysis of vinca alkaloids in plasma and urine using high-performance liquid chromatography with electrochemical detection

1 reference

https://pubmed.ncbi.nlm.nih.gov/1283846

12 December 2020

Overcoming of vincristine resistance in P388 leukemia in vivo and in vitro through enhanced cytotoxicity of vincristine and vinblastine by verapamil

1 reference

https://pubmed.ncbi.nlm.nih.gov/1283846

12 December 2020

Pharmacology of drugs that alter multidrug resistance in cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/1283846

12 December 2020

Modulation of membrane drug permeability in Chinese hamster ovary cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/1283846

12 December 2020

Comparison of the effects of vinblastine, vincristine, vindesine, and vinepidine on microtubule dynamics and cell proliferation in vitro

1 reference

https://pubmed.ncbi.nlm.nih.gov/1283846

12 December 2020

Mechanism of Cellular Drug Resistance

1 reference

https://pubmed.ncbi.nlm.nih.gov/1283846

12 December 2020

Differential amplification and disproportionate expression of five genes in three multidrug-resistant Chinese hamster lung cell lines

1 reference

https://pubmed.ncbi.nlm.nih.gov/1283846

12 December 2020

Pleiotropic phenotype of colchicine-resistant CHO cells: cross-resistance and collateral sensitivity

1 reference

https://pubmed.ncbi.nlm.nih.gov/1283846

12 December 2020

Monoclonal antibodies to antitumor Vinca alkaloids: thermodynamics and kinetics

1 reference

https://pubmed.ncbi.nlm.nih.gov/1283846

12 December 2020

1 reference

https://pubmed.ncbi.nlm.nih.gov/1283846

12 December 2020

Pharmacokinetics and metabolism of vinblastine in humans

1 reference

https://pubmed.ncbi.nlm.nih.gov/1283846

12 December 2020

High-performance liquid chromatographic determination of vinca-alkaloids in plasma and urine

1 reference

https://pubmed.ncbi.nlm.nih.gov/1283846

12 December 2020

Alternate overexpression of two P-glycoprotein [corrected] genes is associated with changes in multidrug resistance in a J774.2 cell line

1 reference

https://pubmed.ncbi.nlm.nih.gov/1283846

12 December 2020

Continued expression of vinca alkaloid resistance by CCRF-CEM cells after treatment with tunicamycin or pronase.

1 reference

https://pubmed.ncbi.nlm.nih.gov/1283846

12 December 2020

New antitumor monoclonal antibody-vinca conjugates LY203725 and related compounds: design, preparation, and representative in vivo activity

1 reference

https://pubmed.ncbi.nlm.nih.gov/1283846

12 December 2020

Experimental antitumor activity of Navelbine

1 reference

https://pubmed.ncbi.nlm.nih.gov/1283846

12 December 2020

Vincristine neurotoxicity. Pathophysiology and management.

1 reference

https://pubmed.ncbi.nlm.nih.gov/1283846

12 December 2020

Clinical pharmacokinetics of vindesine infusion

1 reference

https://pubmed.ncbi.nlm.nih.gov/1283846

12 December 2020

Toxicity and pharmacology of bolus vindesine injection and prolonged vindesine infusion

1 reference

https://pubmed.ncbi.nlm.nih.gov/1283846

12 December 2020

Immunofluorescence study of the action of navelbine, vincristine and vinblastine on mitotic and axonal microtubules

1 reference

https://pubmed.ncbi.nlm.nih.gov/1283846

12 December 2020

Toxicology of vindesine (desacetyl vinblastine amide) in mice, rats, and dogs

1 reference

https://pubmed.ncbi.nlm.nih.gov/1283846

12 December 2020

Continuous infusion vindesine in solid tumors

1 reference

https://pubmed.ncbi.nlm.nih.gov/1283846

12 December 2020

Oral administration of [3H]navelbine in patients: comparative pharmacokinetics using radioactive and radioimmunologic determination methods

1 reference

https://pubmed.ncbi.nlm.nih.gov/1283846

12 December 2020

A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants

1 reference

https://pubmed.ncbi.nlm.nih.gov/1283846

12 December 2020

Monoclonal antibodies to glycoproteins of Vinca alkaloid-resistant human leukemic cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/1283846

12 December 2020

Overexpression and amplification of five genes in a multidrug-resistant Chinese hamster ovary cell line

1 reference

https://pubmed.ncbi.nlm.nih.gov/1283846

12 December 2020

Atypical multidrug resistance in a therapy-induced drug-resistant human leukemia cell line (LALW-2): resistance to Vinca alkaloids independent of P-glycoprotein

1 reference

https://pubmed.ncbi.nlm.nih.gov/1283846

12 December 2020

Characterization of a new drug-resistant human myeloma cell line that expresses P-glycoprotein.

1 reference

https://pubmed.ncbi.nlm.nih.gov/1283846

12 December 2020

GTP influences the binding of vincristine in human tumor cytosols

1 reference

https://pubmed.ncbi.nlm.nih.gov/1283846

12 December 2020

Differential activity of vincristine and vinblastine against cultured cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/1283846

12 December 2020

Comparative pharmacokinetics of antitumor Vinca alkaloids: intravenous bolus injections of navelbine and related alkaloids to cancer patients and rats

1 reference

https://pubmed.ncbi.nlm.nih.gov/1283846

12 December 2020

Correlation of biologic data with physico-chemical properties among the Vinca alkaloids and their congeners

1 reference

https://pubmed.ncbi.nlm.nih.gov/1283846

12 December 2020

In vivo and in vitro pharmacokinetics and metabolism of vincaalkaloids in rat. I. Vindesine (4-deacetyl-vinblastine 3-carboxyamide)

1 reference

https://pubmed.ncbi.nlm.nih.gov/1283846

12 December 2020

THE VINCA ALKALOIDS: A NEW CLASS OF ONCOLYTIC AGENTS.

1 reference

https://pubmed.ncbi.nlm.nih.gov/1283846

12 December 2020

Pharmacological properties of a new alpha-aminophosphonic acid derivative of vinblastine

1 reference

https://pubmed.ncbi.nlm.nih.gov/1283846

12 December 2020

Differential cellular retention of vincristine and vinblastine by cultured human promyelocytic leukemia HL-60/Cl cells: the basis of differential toxicity

1 reference

https://pubmed.ncbi.nlm.nih.gov/1283846

12 December 2020

The binding of vincristine, vinblastine and colchicine to tubulin

1 reference

https://pubmed.ncbi.nlm.nih.gov/1283846

12 December 2020

Pharmacokinetic and preliminary metabolic fate of navelbine in humans as determined by high performance liquid chromatography

1 reference

https://pubmed.ncbi.nlm.nih.gov/1283846

12 December 2020

Pharmacokinetics of a new anticancer drug, navelbine, in patients. Comparative study of radioimmunologic and radioactive determination methods

1 reference

https://pubmed.ncbi.nlm.nih.gov/1283846

12 December 2020

10.2165/00003495-199200444-00002

Identifiers

DOI

0 references

Dimensions Publication ID

1018352131

0 references

1 reference